AC
NVO

Arjuna Capital’s Novo Nordisk NVO Stock Holding History

Arjuna Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,652
Closed -$1.98M – 121
2025
Q3 		$1.98M Buy
35,652
+1,209
+4% +$70.8K 0.49% 49
2025
Q2 		$2.38M Sell
34,443
-1,196
-3% -$81.4K 0.63% 41
2025
Q1 		$2.47M Sell
35,639
-1,878
-5% -$155K 0.69% 40
2024
Q4 		$3.23M Sell
37,517
-9,750
-21% -$1.05M 0.86% 36
2024
Q3 		$5.63M Sell
47,267
-6,116
-11% -$816K 1.46% 17
2024
Q2 		$7.62M Sell
53,383
-17
-0% -$2.25K 2.05% 11
2024
Q1 		$6.86M Buy
53,400
+10,696
+25% +$1.27M 1.94% 14
2023
Q4 		$4.42M Buy
42,704
+2,106
+5% +$208K 1.38% 23
2023
Q3 		$3.69M Sell
40,598
-716
-2% -$63.1K 1.32% 22
2023
Q2 		$3.34M Buy
41,314
+158
+0.4% +$12.9K 1.18% 25
2023
Q1 		$3.27M Sell
41,156
-6,412
-13% -$455K 1.28% 18
2022
Q4 		$3.22M Sell
47,568
-1,230
-3% -$72.1K 1.48% 20
2022
Q3 		$2.43M Buy
48,798
+1,652
+4% +$88.5K 1.2% 26
2022
Q2 		$2.63M Buy
47,146
+992
+2% +$55K 1.27% 26
2022
Q1 		$2.56M Sell
46,154
-2,268
-5% -$116K 1.07% 25
2021
Q4 		$2.71M Buy
48,422
+5,846
+14% +$317K 0.99% 30
2021
Q3 		$2.04M Buy
42,576
+4,928
+13% +$238K 0.83% 37
2021
Q2 		$1.58M Buy
37,648
+5,988
+19% +$232K 0.68% 48
2021
Q1 		$1.07M Buy
31,660
+25,232
+393% +$899K 0.52% 54
2020
Q4 		$224K Buy
6,428
+106
+2% +$3.66K 0.12% 87
2020
Q3 		$219K Sell
6,322
-294
-4% -$9.8K 0.14% 79
2020
Q2 		$217K Buy
+6,616
New +$211K 0.15% 83

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arjuna Capital's NVO Position: Q4 2025 in Review

Arjuna Capital sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 35,652 shares — an estimated $1.98M sold.

Arjuna Capital first reported a position in NVO in Q2 2020 and held it in 22 quarters. The position peaked at $7.62M in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Arjuna Capital reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Arjuna Capital sold 35,652 Novo Nordisk shares in Q4 2025, an estimated $1.98M.
  • Arjuna Capital first reported a position in Novo Nordisk in Q2 2020 and held it in 22 quarters.
  • Arjuna Capital's Novo Nordisk position peaked at $7.62M in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Arjuna Capital's 13F filing for Q4 2025, filed 5 Feb 2026.